CP

Chris Purple

Director, Medical Outcomes Liaison at Akebia Therapeutics

Chris Purple has a diverse work experience in the pharmaceutical and medical industries. Chris currently holds the position of Director, Medical Outcomes Liaison at Akebia Therapeutics, starting in May 2022. Prior to this, they served as the Associate Director, Medical Outcomes Liaison at the same company starting in April 2021. Before joining Akebia Therapeutics, Chris worked at Eisai US as a Sr. Medical Science Liaison in Neurology from January 2019 to April 2021. Chris also held the position of Senior Medical Science Liaison at Sanofi Biosurgery Inc. from August 2012 to January 2019. Chris has previous experience as a Medical Science Liaison at Teva Pharmaceuticals from April 2012 to August 2012. Chris also worked as a Regional Scientific Manager at AstraZeneca from February 2011 to February 2012. During their career, Chris held the position of Senior Scientist, Medical Affairs at Warner Chilcott following their acquisition of Procter & Gamble Pharmaceuticals from February 2010 to July 2010. Before that, they worked at Procter & Gamble Pharmaceuticals as a Senior Scientist in Medical Affairs from an unknown start date to February 2010 and as a Scientist & Discovery Research Project Leader from an unknown start date to an unknown end date. Chris began their professional journey as a Research Fellow at Washington University School of Medicine from August 1998 to January 2002 in the Department of Orthopaedic Surgery.

Chris Purple's education history begins with attending Howe Military School at an unknown time.

After that, Chris went on to earn a Bachelor of Science degree in Botany from Eastern Illinois University, which was completed during the years 1986 to 1988.

Following the undergraduate degree, Chris pursued a Master of Science degree in Cell Biology from the University of Illinois Chicago, which was achieved from 1990 to 1993.

Continuing the educational journey, Chris completed a Ph.D. in Biochemistry from Rush University between the years 1993 and 1998.

Finally, in 1986, Chris also briefly studied the German Language at the Gӧthe Institut in Germany, although no degree was attained during this time.

Links

Previous companies

Eisai logo
Teva Pharmaceutical Industries logo
AstraZeneca logo
Procter & Gamble logo

Timeline

  • Director, Medical Outcomes Liaison

    May, 2022 - present

  • Associate Director Medical Outcomes Liaison

    April, 2021

View in org chart